Skip to main content

HCW Biologics Inc.

corporate_fare Company Profile

HCW Biologics Inc.

HCWB·NASDAQ·Life Sciences·CIK 0001828673

HCW Biologics Inc. is a clinical-stage biopharmaceutical company focused on developing fusion immunotherapeutics to treat diseases linked to chronic inflammation. The company has created novel compounds intended to treat autoimmune disorders, other proinflammatory diseases, cancer, and senescence-associated dysplasia. HCW Biologics has also started commercializing certain proprietary compounds for use as reagents in producing immunotherapeutics for infectious diseases and cancer. The company's approach targets chronic inflammation, which is believed to contribute to many diseases. This inflammation results from persistent immune cell activation and the buildup of senescent cells, which are non-proliferative but metabolically active. While senescence is a normal physiological process involved in wound healing, tissue maintenance, regeneration, embryogenesis, fibrosis regulation, and tumor suppression, the accumulation of senescent cells with Senescence-Associated Phenotype (SASP) proinflammatory factors is implicated as a major source of chronic sterile inflammation leading to aging-related pathologies. SASP factors, including proinflammatory cytokines, chemokines, and proteinases, drive an inflammation cycle. Over time, various insults cause normal tissue cells to become senescent, releasing SASP factors that activate immune cells. Prolonged immune cell activation also releases highly proinflammatory cytokines, leading to chronic low-grade inflammation and perpetuating this cycle. Two of the company's proprietary molecules, HCW9201 and HCW9206, are ready for commercial use as reagents in immunotherapeutic treatments.

HCW Biologics Inc. (NASDAQ:HCWB) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 65 items for HCWB at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • HCW Biologics Prices $4M Private Placement, Adding to Recent Dilution
  • Q1 Earnings Show Revenue Surge, But Going Concern and Control Weakness Persist
  • HCW Biologics Reports Q1 Net Income of $3.5M, Appeals Nasdaq Delisting
  • HCW Biologics Posts $6.5M Q1 Revenue, Bolstering Finances Amid Delisting Concerns
  • Early Data: HCW Biologics' HCW11-040 Prevents Bronchopulmonary Dysplasia

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$54.23K
Net Income
-$7.96M
Diluted EPS
-$10.63
Op. Cash Flow
-$13.39M
Free Cash Flow
-$13.39M
Gross Profit
$10.85K
Operating Income
-$13.16M
Cash & Equivalents
$1.95M
Total Debt
$6.81M
Debt / Equity
2.46×
Net Margin
-146.77×
Shares Outstanding
2.1M sh
Source: 10-K · filed 2026-03-31 · accession 0001193125-26-134934
$0.7673 +4.38% today
52-week range · as of 2026-11-18 $0.7428 – $23.94
Market cap
$2.35M
Volume
23.6K (0.2× avg)
3-mo avg 116.5K
Live data · 2026-11-22 13:02 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed HCWB - Filings & News (Page 3)

HCWB
May 21, 2026, 9:54 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $2.04
Real-time Price: $0.7673 info
Change: Reverse Stock Split info
Market Cap: $2.352M info
HCWB
May 14, 2026, 4:31 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.708
Real-time Price: $0.7673 info
Change: Reverse Stock Split info
Market Cap: $2.352M info
HCWB
May 14, 2026, 4:31 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.6987
Real-time Price: $0.7673 info
Change: Reverse Stock Split info
Market Cap: $2.352M info
HCWB
May 14, 2026, 4:25 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.337
Real-time Price: $0.7673 info
Change: Reverse Stock Split info
Market Cap: $2.352M info
HCWB
May 14, 2026, 7:32 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.3584
Real-time Price: $0.7673 info
Change: Reverse Stock Split info
Market Cap: $2.352M info
HCWB
Apr 30, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.4349
Real-time Price: $0.7673 info
Change: Reverse Stock Split info
Market Cap: $2.352M info
HCWB
Apr 30, 2026, 4:20 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.4499
Real-time Price: $0.7673 info
Change: Reverse Stock Split info
Market Cap: $2.352M info
HCWB
Apr 29, 2026, 9:24 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.3842
Real-time Price: $0.7673 info
Change: Reverse Stock Split info
Market Cap: $2.352M info
HCWB
Apr 29, 2026, 11:24 AM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $0.4002
Real-time Price: $0.7673 info
Change: Reverse Stock Split info
Market Cap: $2.352M info
HCWB
Apr 23, 2026, 5:12 PM EDT
Filing Type: S-1
Importance Score:
9
Price at Filing: $0.4099
Real-time Price: $0.7673 info
Change: Reverse Stock Split info
Market Cap: $2.352M info
HCWB
Apr 17, 2026, 5:23 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.4255
Real-time Price: $0.7673 info
Change: Reverse Stock Split info
Market Cap: $2.352M info
HCWB
Apr 16, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.4058
Real-time Price: $0.7673 info
Change: Reverse Stock Split info
Market Cap: $2.352M info
HCWB
Mar 31, 2026, 5:12 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.3509
Real-time Price: $0.7673 info
Change: Reverse Stock Split info
Market Cap: $2.352M info
HCWB
Mar 31, 2026, 5:08 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.363
Real-time Price: $0.7673 info
Change: Reverse Stock Split info
Market Cap: $2.352M info
HCWB
Mar 17, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $0.8116
Real-time Price: $0.7673 info
Change: Reverse Stock Split info
Market Cap: $2.352M info
HCWB
Mar 17, 2026, 7:50 AM EDT
Source: GlobeNewswire
Importance Score:
10
Price at Filing: $0.841
Real-time Price: $0.7673 info
Change: Reverse Stock Split info
Market Cap: $2.352M info
HCWB
Mar 16, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.5627
Real-time Price: $0.7673 info
Change: Reverse Stock Split info
Market Cap: $2.352M info
HCWB
Mar 13, 2026, 4:15 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $0.5161
Real-time Price: $0.7673 info
Change: Reverse Stock Split info
Market Cap: $2.352M info
HCWB
Mar 02, 2026, 8:08 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.554
Real-time Price: $0.7673 info
Change: Reverse Stock Split info
Market Cap: $2.352M info
HCWB
Feb 19, 2026, 4:43 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.5705
Real-time Price: $0.7673 info
Change: Reverse Stock Split info
Market Cap: $2.352M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets